Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Research In Brief

This article was originally published in The Gray Sheet

Executive Summary

Cook hemostasis spray: Early results of a safety study conducted in China show firm's endoscopic spray helps patients with peptic ulcer bleeds achieve hemostasis and stops re-bleeding, Cook reports April 7. Featuring a proprietary powder that can be sprayed directly onto a bleeding ulcer through the channel of an endoscope, the product may offer an alternative to devices like heating probes and clips in treating gastrointestinal (GI) bleeding, Barry Slowey, global business unit leader for Cook's endoscopy unit, said in an interview. Depending on the results of the 20-patient safety trial, which will be presented at the 2010 Digestive Disease Week conference in May, Cook will decide whether to move forward with a larger clinical study of the spray for GI bleeding by mid-year. About four to five million patients are treated annually for GI bleeds, representing a market of $160 million, Slowey noted

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028739

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel